Introducing HALO AP Dx: An Enterprise Pathology Platform for Primary Diagnosis | June 13

Learn how the 510(k)-cleared HALO AP Dx platform can be used for comprehensive workflows in primary diagnostics

Introducing HALO AP Dx: An Enterprise Pathology Platform for Primary Diagnosis

Date: 13 June 2024
Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 16:00 – 17:00 BST
Location: Webinar

Summary

Join Indica for this 1-hour webinar to see a live demonstration of HALO AP Dx, the 510(k)-cleared digital pathology platform from Indica Labs. Eric Runde, Chief Operating Officer at Indica Labs, will present an introduction to HALO AP Dx and will demonstrate how the platform enables efficient diagnostic workflows. Learn how HALO AP Dx automatically organizes images, metadata, gross details, and patient information into casesfacilitates case prioritization and sign-out, and enables ergonomic image navigationSee common anatomic pathology workflowin action and discover how HALO AP Dx modernizes tumor boards and promotes streamlined management of clinical trials.

HALO AP Dx (K232833) is FDA-cleared for primary diagnostic use with the Hamamatsu NanoZoomer® S360MD Slide scanner in the US. In addition, HALO AP Dx provides built-in compliance and certifications with FDA 21 CFR Part 11, ISO 13485:2016, and HIPAA.

HALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AP® is For Research Use Only in the US and is not FDA cleared for clinical diagnostic use. In addition, HALO AP® provides built-in compliance and certifications with FDA 21 CFR Part 11, ISO 13485:2016, HIPAA, and GDPR. 

Learning Objectives

  • Learn how HALO AP Dx provides tools and workflows for efficient image evaluation, management, and collaboration 
  • Experience common anatomic pathology workflows including evaluation of H&E and IHC images from sign out to reporting
  • Learn how HALO AP Dx facilitates clinical trial management and tumor boards 

Presenter

Eric Runde
Chief Operating Officer
Indica Labs

Eric Runde joined Indica Labs in 2020 as the Principal Product Manager for HALO AP® and subsequently took on the role of Chief Operating Officer in 2021. Prior to Indica Labs, Eric was a product manager at Varian Medical Systems after their acquisition of Mobius Medical Systems where he held product and customer support management roles. He earned a BS in Mechanical Engineering from University of Missouri and MS from University of Minnesota with a research emphasis on plasma science and nanotechnology.

Share This Post